Clinical Trial: A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.
Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.
Current Primary Outcome: Score of the Corneal conjunctival staining
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Kissei Pharmaceutical Co., Ltd.
Dates:
Date Received: September 20, 2012
Date Started:
Date Completion:
Last Updated: May 29, 2014
Last Verified: May 2014